ONCOGENIC TRANSFORMATION PRODUCED BY AGENTS AND MODALITIES USED IN CANCER THERAPY AND ITS MODULATION*
1982; Wiley; Volume: 397; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1982.tb43427.x
ISSN1749-6632
Autores Tópico(s)Cancer Treatment and Pharmacology
ResumoAnnals of the New York Academy of SciencesVolume 397, Issue 1 p. 193-210 ONCOGENIC TRANSFORMATION PRODUCED BY AGENTS AND MODALITIES USED IN CANCER THERAPY AND ITS MODULATION* Carmia Borek, Carmia Borek Radiological Research Laboratory Department of Radiology and Pathology Cancer Center/Institute of Cancer Research Columbia University College of Physicians and Surgeons New York, New York 10032Search for more papers by this authorEric J. Hall, Eric J. Hall Radiological Research Laboratory Department of Radiology and Pathology Cancer Center/Institute of Cancer Research Columbia University College of Physicians and Surgeons New York, New York 10032Search for more papers by this author Carmia Borek, Carmia Borek Radiological Research Laboratory Department of Radiology and Pathology Cancer Center/Institute of Cancer Research Columbia University College of Physicians and Surgeons New York, New York 10032Search for more papers by this authorEric J. Hall, Eric J. Hall Radiological Research Laboratory Department of Radiology and Pathology Cancer Center/Institute of Cancer Research Columbia University College of Physicians and Surgeons New York, New York 10032Search for more papers by this author First published: December 1982 https://doi.org/10.1111/j.1749-6632.1982.tb43427.xCitations: 2 * This investigation was supported by Grant CA 12536-11 to the Radiological Research Laboratory/Department of Radiology. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Arseneau, J., G. P. Caneixas, R. Johnson & V. T. Devita. 1977. Risk of new cancer in patients with Hodgkins disease. Cancer 40: 1912–1916. 2 Borek, C. & L. Sachs. 1966. In vitro cell transformation by x-irradiation. Nature 210: 276–278. 3 Borek, C. & L. Sachs. 1967. Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. Proc. Natl. Acad. Sci. USA 57: 1522–1527. 4 Borek, C. & L. Sachs. 1968. The number of cell generations required to fix the transformed state in x-ray induced transformation. Proc. Natl. Acad. Sci. USA 59: 83–85. 5 Borek, C, C. Pain & H. Mason. 1976. Transformation of embryo cells x irradiated in utero and assayed in vitro: Qualitative and quantitative aspects. Radiat. Res. 67, 68: 629. 6 Borek, C. & C. M. Fenoglio. 1976. A scanning electron microscope study of surface features of hamster embryo cells transformed in vitro by x-irradiation. Cancer Res. 36: 1325–1334. 7 Borek, C. & D. L. Guernsey. 1981. Thyroid hormone modulated neoplastict ransformation in vitro. J. Supramol. Struct. and Cell. Biochem. Suppl. 5: 218. 8 Borek, C, E. J. Hall & H. H. Rossi. 1978. Malignant transformation in cultured hamster embryo cells produced by x rays, 450 keV monoenergetic neutrons and heavy ions. Cancer Res. 38: 2997–3005. 9 Borek, C. & E. J. Hall. 1973. Transformation of mammalian cells in vitro by low doses of x-rays. Nature 244: 450–453. 10 Borek, C. & E. J. Hall. 1974. Cell transformation in vitro by monoenergetic neutrons. J. Cell Biol. 63: 33a. 11 Borek, C. 1979. Neoplastic transformation following split doses of x-rays. Brit. J. Radiol. 52: 845. 12 Borek, C, E. J. Hall & M. Zaider. The oncogenic potential of x-rays and γ-rays in vitro. Radiat. Res. In press. 13 Reznikoff, C. A., J. S. Bertram, D. W. Brankow & C. Heidelberger. 1973. Quantitative and qualitative studies of chemical transformations of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33: 3239–3249. 14 Borek, C, R. Miller, C. Pain & W. Troll. 1979. Conditions for the inhibiting and enhancing effect of protease inhibitor Antipain on x-ray induced neoplastic transformation in hamster and mouse cells. Proc. Natl. Acad. Sci. USA 76: 1800–1803. 15 Borek, C, R. C. Miller, C. R. Geard, D. Guernsey, R. S. Osmak, M. Rutledge-freeman, A. Ong & H. Mason. 1981. Modulating effect of retinoids and tumor promoters on malignant transformation, sister chromatid exchanges and Na/K ATPase. In Modulation of Cellular Interaction by Vitamin A and Derivatives (Retinoids). L. M. DeLuca and S. S. Shapiro, eds. Ann. NY Acad. Sci. 359: 237–238. 16 Miller, R. C, C. R. Geard, R. S. Osmak, M. Rutledge-freeman, A. Ong, H. Mason, A. Napholz, N. Perez, L. Harisiadis & C. Borek. 1981. Modification of sister chromatid exchanges and radiation-induced transformation in rodent cells by the tumor promotor 12-0-tetradecanoylphorbol-13-acetate and two retinoids. Cancer Res. 41: 655–659. 17 Miller, R. & E. J. Hall. 1978. X-ray dose fractionation and oncogenic transformations in cultured mouse embryo cells. Nature 272: 58–60. 18 Guernsey, D. L., A. Ong & C. Borek. 1980. Thyroid hormone modulation of x ray-induced in vitro neoplastic transformation. Nature 288: 591–592. 19 Little, J. B. 1979. Quantitative studies of radiation transformation with the A31-11 mouse BALB/3T3 cell line. Cancer Res. 39: 1474–1480. 20 Hall, E. J., R. C. Miller, R. Osmak & M. Zimmerman. 1982. A comparison of the incidence of oncogenic transformation produced by x-rays, misonidazole and chemotherapeutic agents. Radiology. In press. 21 Miller, R. C. & E. J. Hall. 1978. Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole. Br. J. Cancer 38: 411–417. 22 Mansy, S., B. Rosenberg & A. J. Thompson. 1973. Binding of cis and trans dichloramine platinum to nucleosides. J. Am. Chem. Soc. 95: 1633–1640. 23 Pascoe, J. M. & J. J. Roberts. 1974. Interactions between mammalian cell DNA and inorganic platinum compounds. Biochem. Pharmacol. 23: 1345–1357. 24 Zwelling, L. A., T. Anderson & K. W. Kohn. 1979. DNA-protein and DNA interstrand crosslinking by cis- and trans-platinum (II) diamminedichloride in L1210 mouse leukemia cells, and relation to cytotoxicity. Cancer Res. 39: 365–369. 25 Zwelling, L. A., Bradley, O. Matthews, N. A. Sharkey, T. Anderson & K. W. Kohn. 1979. Mutagenicity, cytotoxicity and DNA crosslinking in V79 Chinese hamster cells treated with cis- and trans-Pt (II) diamminedi-chloride. Mutation Res. 67: 271–280. 26 Benedict, W. F., A. Banerjee, A. Gardner & P. A. Jones. 1977. Induction of morphological transformation in mouse C3H/10TVi clone 8 cells and chromosomal damage in hamster cells by cancer chemotherapeutic agents. Cancer Res. 37: 2202–2208. 27 Turnbull, D., N. C. Popescu, J. A. Dipaolo & B. C. Myhr. 1979. Cis-Platinum (II) diamine dichloride causes mutation, transformation, and sister chromatid exchanges in cultured mammalian cells. Mutation Res. 66: 267–275. 28 Marquardt, H., F. S. Phillips & S. S. Sternberg. 1976. Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin. Cancer Res. 36: 2065–2069. 29 Hecker, E. et al., Eds. 1982. Carcinogenesis and Biological Effects of Tumor Promoters. Raven Press. New York , NY . 30 Doll, R. & R. Peto. 1981. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66: 1193–1308. 31 Borek, C. 1982. Vitamins and micronutrients modify carcinogenesis and tumor promotion in vitro. In Molecular Interrelations of Nutrition and Cancer. M. Arnot et al, Eds.: 337–350. Raven Press. New York , NY . 32 Guernsey, D. L., C. Borek & I. S. Edelman. 1981. Crucial role of thyroid hormone in x-ray-induced neoplastic transformation in cell culture. Proc. Natl. Acad. Sci. USA 78: 5708–5711. 33 Borek, C, D. L. Guernsey, A. Ong & I. S. Edelman Proc. Natl. Acad. Sci. USA In press. 34 Miller, R. C, R. Osmak, M. Zimmerman & E. J. Hall. 1982. Sensitizers, protectors and oncogenic transformation in vitro. Int. J. Rad. Oncol. Biol. Phys. 8: 771–775. 35 Borek, C. & W. Troll. Modifiers of free radicals inhibit in vitro the oncogenic action of x rays, bleomycin and the tumor promotor TPA. Proc. Natl. Acad. Sci. USA. In press. 36 Borek, C. X-ray-induced transformation of human diploid cells. Nature 283: 776–778. 37 Harisidiadis, L., R. C. Miller, E. J. Hall & C. Borek. 1978. Vitamin A analogue inhibits radiation-induced oncogenic transformation. Nature 274: 486–487. Citing Literature Volume397, Issue1Cell Proliferation, Cancer, and Cancer Therapy: A Conference in Honor of Anna GoldfederDecember 1982Pages 193-210 ReferencesRelatedInformation
Referência(s)